Cover Image
市場調查報告書

愛迪生氏症(原發性或慢性腎上腺皮質機能不全):全球臨床實驗檢討

Addison's Disease (Primary or Chronic Adrenal Insufficiency) Global Clinical Trials Review, H2, 2016

出版商 GlobalData 商品編碼 301446
出版日期 內容資訊 英文 49 Pages
訂單完成後即時交付
價格
Back to Top
愛迪生氏症(原發性或慢性腎上腺皮質機能不全):全球臨床實驗檢討 Addison's Disease (Primary or Chronic Adrenal Insufficiency) Global Clinical Trials Review, H2, 2016
出版日期: 2016年09月30日 內容資訊: 英文 49 Pages
簡介

本報告提供愛迪生氏症的治療藥相關臨床實驗調查分析,提供臨床實驗數及被實驗人數,階段及Phase別狀況,有潛力的企業,正在開發的治療藥資訊,臨床實驗簡介等,為您概述為以下內容。

目錄

簡介

各地區的臨床實驗

  • 各國臨床實驗數·平均實驗人數
    • 亞太地區的主要國家
    • 歐洲的主要5個國家
    • 北美的主要國家
    • 中東·非洲的主要國家
    • 中南美的主要國家

G7各國的臨床實驗:代謝障礙臨床實驗中愛迪生氏症的比例

G7各國的臨床實驗:各階段

G7各國的臨床實驗:各臨床實驗狀況

E7各國的臨床實驗:代謝障礙臨床實驗中愛迪生氏症的比例

E7各國的臨床實驗:各臨床實驗狀況

E7各國的臨床實驗:各階段

各階段臨床實驗

Phase別臨床實驗

評估項目別臨床實驗

未完成的臨床實驗

一定期間所採用的實驗對象

贊助商各類型臨床實驗

有潛力的贊助商

  • 參與愛迪生氏症的治療藥臨床實驗的主要企業

有前途藥物

臨床實驗簡介

  • 主要企業臨床實驗概要
  • 主要研究機關·醫院臨床實驗概要

5個主要的臨床簡介

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC3796CTIDB

GlobalData's clinical trial report, "Addison's Disease (Primary or Chronic Adrenal Insufficiency) Global Clinical Trials Review, H2, 2016" provides an overview of Addison's Disease (Primary or Chronic Adrenal Insufficiency) clinical trials scenario. This report provides top line data relating to the clinical trials on Addison's Disease (Primary or Chronic Adrenal Insufficiency). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Contents

Table of Contents 2

  • List of Tables 3
  • List of Figures 3
  • Report Guidance 5
  • Clinical Trials by Region 6
  • Clinical Trials and Average Enrollment by Country 7
  • Top Countries Contributing to Clinical Trials in Asia-Pacific 10
  • Top Five Countries Contributing to Clinical Trials in Europe 11
  • Top Countries Contributing to Clinical Trials in North America 12
  • Clinical Trials by G7 Countries: Proportion of Addison's Disease (Primary or Chronic Adrenal Insufficiency) to Hormonal Disorders Clinical Trials 13
  • Clinical Trials by Phase in G7 Countries 15
  • Clinical Trials in G7 Countries by Trial Status 16
  • Clinical Trials by Phase 17
  • In Progress Trials by Phase 18
  • Clinical Trials by Trial Status 19
  • Clinical Trials by End Point Status 20
  • Subjects Recruited Over a Period of Time 21
  • Clinical Trials by Sponsor Type 22
  • Prominent Sponsors 23
  • Top Companies Participating in Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Clinical Trials 24
  • Prominent Drugs 25
  • Clinical Trial Profile Snapshots 26

Appendix 53

  • Abbreviations 53
  • Definitions 53
  • Research Methodology 54
  • Secondary Research 54
  • About GlobalData 55
  • Contact Us 55
  • Disclaimer 55
  • Source 56

List of Tables

  • Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics, Global, Clinical Trials by Region, 2016* 6
  • Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
  • Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 9
  • Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2016* 10
  • Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 11
  • Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Clinical Trials, North America, Top Countries, 2016* 12
  • Proportion of Addison's Disease (Primary or Chronic Adrenal Insufficiency) to Hormonal Disorders Clinical Trials, G7 Countries (%), 2016* 13
  • Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15
  • Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16
  • Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics, Global, Clinical Trials by Phase, 2016* 17
  • Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 18
  • Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics, Global, Clinical Trials by Trial Status, 2016* 19
  • Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Clinical Trials, Global, by End Point Status, 2016* 20
  • Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 21
  • Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 22
  • Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 23
  • Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 24
  • Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 25

List of Figures

  • Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics, Global, Clinical Trials by Region (%), 2016* 6
  • Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
  • Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 9
  • Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 11
  • Proportion of Addison's Disease (Primary or Chronic Adrenal Insufficiency) to Hormonal Disorders Clinical Trials, G7 Countries (%), 2016* 13
  • Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15
  • Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16
  • Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics, Global, Clinical Trials by Phase (%), 2016* 17
  • Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 18
  • Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics, Global, Clinical Trials by Trial Status, 2016* 19
  • Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Clinical Trials, Global, by End Point Status, 2016* 20
  • Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 21
  • Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 22
  • Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 23
  • Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 24
  • Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 25
  • GlobalData Methodology 54
Back to Top